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a b s t r a c t
Within past decades the clear trend towards the shortening of the hospital stay in patients
with myocardial infarction with ST segment elevations (STEMI) has been observed. The
current Guidelines of European Society of Cardiology for the management of acute STEMI
state, that in the selected patients may be considered early discharge (after approximately
72 h), if adequate follow-up is arranged.
Authors present prospective analysis of 25 low risk patients with STEMI, treated with
successful primary percutaneous coronary intervention (PCI) and discharged within 48–72 h
after admission.
Only 1 unplanned hospitalization for non-cardiac cause and no other serious complica-
tions were observed within 30-day follow-up.
Presented data demonstrate that early discharge after STEMI in selected low risk patients
is feasible and safe with regard to the conditions of regular clinical practice. This strategy
applies to at least 14% patients with low risk of subsequent complications.
# 2014 Published by Elsevier Urban & Partner Sp. z o.o. on behalf of the Czech Society of
Cardiology.
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Within past decades the clear trend towards the shortening of
the hospital stay in patients admitted with the diagnosis of
STEMI has been observed [1]. Together with that it has been
repeatedly proved that the reduced hospital stay leads to
reduction of health cost [2–4].
The current Guidelines of European Society of Cardiology
for the management of acute myocardial infarction with ST-
segment elevation, released in 2012, state, that in the selected
patients may be considered (class of recommendation IIb)
early discharge (after approximately 72 h), if adequate follow-
up is arranged [5]. Level of evidence of cited recommendation
is B, i.e. it is based on data, derived from a single randomized
clinical trial or large non-randomized studies. The data of its
implementation to clinical practice have been quite limited.
The aim of our prospective analysis is to assess feasibility
and safety of the early discharge (48–72 h) in the conditions of
everyday clinical practice, the portion of patients, this
strategy could be applied to, as well as to encourage wider
discussion in order to provide this approach to the greatest
number of patients with regard to their safety, comfort and
preference.
Methods
179 consecutive patients with diagnosis of STEMI, treated with
primary PCI were admitted to our centre within the period
between February 16 and December 20, 2013. 25 (14%) of them
fulﬁlled given criteria for early discharge (Table 1).
Their baseline characteristics are shown in Table 2.
As for reasons excluding patients from the analysis, the most
frequent was the combination of several factors (39%), followedTable 1 – Criteria for early discharge.
 STEMI treated with successful primary PCI within 12 h of
the symptom onset (TIMI ﬂow 3 in infarct-related artery)
 Age ≤75 years
 Left ventricular ejection fraction ≥45%
 One- or two-vessel disease
 No symptoms of residual ischaemia
 Haemodynamical and rhythmical stability
 Absence of comorbidities, requiring continuation of
hospitalization
 Absence of contraindication for dual antiplatelet treatment or
need for anticoagulation
 Supposed cooperation, adherence to medical measures and
social background
TIMI, thrombolysis in myocardial infarction.by low left ventricular ejection fraction (17%), multi-vessel
disease (13%), comorbidities (11%), age (9%) and other rare
factors.
Mean time ‘‘door-to-balloon’’ was 41 min, radial approach
was used in all of probands. Two thirds of implanted stents
were drug-eluting, manual thrombaspiration was used in
almost three quarters of patients. Procedural data are listed in
Table 3.
Not surprisingly the inferior infarctions have predominated
(Fig. 1); accordingly right coronary artery as the infarct-related
artery was present in 60%, before PCI 28% of infarct-related
arteries were totally occluded; on the contrary almost half of
them showed normal ﬂow (Fig. 2).
Our centre does not use ordinarily transport back to
referring hospital; the stress test before discharge is not
routinely performed.
Clinical control in outpatient clinic was performed no later
than 3 days after discharge. All patients completed 30-day
follow-up.
Results
Within 30-day follow-up no death, myocardial infarction (MI),
unstable angina, stroke, repeated target vessel revasculariza-
tion, stent thrombosis or complication associated with arterial
access occurred in studied cohort (Table 4). One patient had to
be rehospitalized for non-cardiac reason (back-pain) in
Department of Neurology, and one patient was 2 days after
discharge examined and treated in Dermatology outpatient
clinic for exanthem of non-allergic origin.
The length of stay was 62  8 h (median 67.5 h, the earliest
discharge in 48 h). Left ventricular ejection fraction, assessed
by echocardiography, was 53  5%.
Discussion
As a logical consequence of advance in therapy and hospital
care including early rehabilitation and mobilization, the lengthTable 2 – Baseline clinical characteristics of the analyzed
cohort.
n = 25
Age (years)  SD 55  11
Female 24%
Diabetes/prediabetes 12%/40%
Hypertension 56%
Smoking 56%
Hyperlipoproteinaemia 60%
History of atherothrombotic complication 4%
Table 3 – PCI – procedural data. Left ventricular ejection
fraction.
n = 25
Time of ischaemia (min)  SD 227  200
Time ‘‘door-to-balloon’’ (min)  SD 41  17
Drug-eluting stents 68%
Aspiration 72%
Radial approach 100%
Left ventricular ejection fraction  SD 53  5%
Fig. 2 – TIMI flow before PCI.
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shortened within past 40 years.
Berger et al. in their population-based study (Minnesota
Heart Survey) concluded that substantial reduction in hospital
length of stay between 1985 and 2001 has not been associated
with increased post-discharge mortality and has been associ-
ated with increasing use of effective therapies [1].
The overview of literature investigating the issue of safety
and feasibility of early discharge in the STEMI population
shows non-uniform methodology of these works (3–63% of
probands fulﬁlled criteria for early discharge!). It could seem
surprising, that the current guidelines for early discharge are
based just on limited data derived from randomized trials.
As far back as in 1988 Topol et al. demonstrated, that in
carefully selected patients with uncomplicated myocardial
infarction, hospital discharge after three days is feasible and
leads to a substantial reduction in hospital charges [2].
At present, the low risk STEMI population is relatively well
deﬁned [6–10]. Several risk scores were created to identify the
patients with low risk of subsequent complications [8–10], who
do not require extensive in-hospital monitoring and observa-
tion.
In the PAMI II study the low risk was deﬁned as follows: age
<70 years, left ventricular ejection fraction >45%, one- or two-
vessel disease, successful percutaneous coronary intervention
and no persistent arrhythmias. STEMI patients were random-
ized to accelerated care (4.2  2.3 days) and traditional care
(7.1  4.7 days) and at 6 months both groups showed no
signiﬁcant difference in mortality, unstable ischaemia, rein-
farction, stroke, heart failure or their combined occurrence [4].
Also substantial cost savings were demonstrated.Fig. 1 – Localization of MI.To assess the feasibility of early discharge, De Luca et al. in
their study developed practical score (Zwolle Risk Score for
STEMI) for risk stratiﬁcation in low risk patients with STEMI,
treated with primary PCI [9]. Independent predictors of 30-day
mortality included in their study were age, anterior infarction,
Killip class, ischaemic time, postprocedural TIMI ﬂow in
infarct-related artery and multi-vessel disease. Score ≤3
designates low-risk patients. 73.4% patients in this trial were
identiﬁed as low-risk group, but among them 16.6% had other
contraindication to early discharge. Thus early discharge
(length of stay 4.3  4.9 days) could have been applied to 61.2%
of the total population with a mortality rate at 2nd day 0.1%
and between 3 and 10 days 0.2%, incidence of malignant
ventricular arrhythmias after 48 h was 0.2%.
In Czech Republic the issue of early discharge was
investigated in PRAGUE 5 study, which after pilot phase
randomized 56 low risk probands with STEMI, discharged even
the next day after successful PCI [11]. It was the ﬁrst study, in
which mean length of stay was shorter than 72 h and to our
best knowledge the only available Czech reference on this
subject.
The strict inclusion criteria (fulﬁlled by only 3% patients
with acute STEMI) included age <75 years, optimal result of
primary PCI, one-vessel disease, left ventricular ejectionTable 4 – Results – clinical outcomes.
Length of hospitalization (h)  SD,
median
62  8, 67.5
Death 0
Myocardial infarction 0
Unstable angina 0
Repeated TVR 0
Stent thrombosis 0
Unplanned rehospitalization 1
Stroke 0
Complications associated with arterial
access
0
Other 1
TVR, target vessel revascularization.
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involved patients after Q-MI, haemodynamically or rhythmi-
cally instable, with recurrent chest pain or clinical or
laboratory ﬁndings requiring additional evaluation. Followed
endpoints involved death, reinfarction, stroke, instable angina
pectoris, repeated target vessel revascularization, local groin
complications requiring treatment and left ventricular ejec-
tion fraction within 30 days. This study also showed, that very
early discharge in clearly deﬁned group of patients is safe,
there was just one rehospitalization due to non-cardiac cause
in the group of 37 patients, discharged the next day after MI,
there was no other serious event in study population.
In the small, pilot SAFE-DEPART study, Kotowycz et al.
randomized 54 low risk patients with STEMI (Zwolle score ≤3),
treated with primary (or rescue) PCI, to the early discharge
(48–72 h) or discharge at the discretion of treating physician
(control group) [12]. The primary outcomes of this study were
to demonstrate feasibility and safety of such an approach. In
the intervention group 74% of patients were discharged within
72 h, length of stay in hospital was short in all study patients
(median 55 h). No death occurred in either group and no
signiﬁcant difference in the rate of rehospitalization between
both groups was observed. There were no signiﬁcant differ-
ences in compliance, quality of life or smoking cessation.
Jones et al. in their prospective observational cohort study
concluded, that over 40% of all patients with STEMI may be
suitable for early discharge with important implications for
healthcare costs [13].
Impressive results were demonstrated in 2013 in retrospec-
tive analysis of Noman et al., who collected data of 2448 STEMI
patients treated with primary PCI and surviving to hospital
discharge [14]. Patients with TIMI 3 ﬂow in infarct-related artery
and without haemodynamic or arrhythmic complications were
considered for early discharge at the discretion of the attending
physician: a total of 1542 patients (63%) were discharged within
2 days of admission (early discharge group) and remaining 37%
after 2 days (late discharge).
The 30-day post-discharge mortality rate was 0.71% in the
early group and 1.66% in the late group. During a mean follow-
up of 584 days, mortality was 4.3% in the early group and 12.3%
in the late group.
The authors conclude that in unselected cohort of
consecutive ‘‘real-world’’ STEMI patients those with low risk
of subsequent complications (almost two thirds!) can be safely
discharged within 2 days following primary PCI.
It is important to stress the fact, that shorter hospital stay
provides just limited time for appropriate patient rehabilita-
tion, education or titration of medication. Thus the early
clinical post-discharge control should be carried out and
subsequent care arranged [5].
Our presented experience, limited to single centre and
small number of probands, correspond to conclusions of
mentioned studies and demonstrate applicability of discharge
within 72 h even in the regular clinical practice (‘‘real world’’
population) in our circumstances. We intend to support our
results with randomized study (registered in the ClinicalTrials.
gov – identiﬁer NCT02023983) and subsequently the revision of
future STEMI guidelines in terms of the level of evidence for
such a strategy as well as the shorter recommended length of
hospital stay.Conclusions
Presented data support the claim that early discharge with
length of stay even shorter than current guidelines recom-
mend in selected low risk patients after STEMI, treated with
successful primary PCI, is possible and safe in the conditions of
everyday clinical practice in Czech Republic. In our analysis,
this strategy applies to at least 14% patients with low risk of
subsequent complications.
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